Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-054513

Chief Scientific Officer sold 3,000 shares at an average $69.79 ($209,377)

  • Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-10-05 Option exercise +3,000 $9.05 $27,150 53,932 D
Biller Scott Chief Scientific Officer 2018-10-05 Sale −900 $68.56 $61,704 53,032 D
Biller Scott Chief Scientific Officer 2018-10-05 Sale −979 $69.47 $68,011 52,053 D
Biller Scott Chief Scientific Officer 2018-10-05 Sale −1,100 $71.05 $78,155 50,953 D
Biller Scott Chief Scientific Officer 2018-10-05 Sale −21 $71.77 $1,507 50,932 D
Derivatives
Biller Scott Chief Scientific Officer 2018-10-05 Option exercise · Stock options (right to buy) −3,000 7,154 D
Open-market sales · 3,000 sh · avg $69.79 · $209,377
Loading xslF345X03/doc4.xml…